These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443 [Abstract] [Full Text] [Related]
3. Impairment of hepatic microcirculation in fatty liver. Ijaz S, Yang W, Winslet MC, Seifalian AM. Microcirculation; 2003 Dec; 10(6):447-56. PubMed ID: 14745457 [Abstract] [Full Text] [Related]
4. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC, Berk PD. Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [Abstract] [Full Text] [Related]
5. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Park SH. Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854 [Abstract] [Full Text] [Related]
6. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Wanless IR, Shiota K. Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490 [Abstract] [Full Text] [Related]
7. Non-alcoholic fatty liver disease and hepatitis C infection. Bondini S, Younossi ZM. Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185 [Abstract] [Full Text] [Related]
8. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A. Eur Rev Med Pharmacol Sci; 2005 Jun; 9(5):273-7. PubMed ID: 16231589 [Abstract] [Full Text] [Related]
9. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. Hakamada K, Sasaki M, Takahashi K, Umehara Y, Konn M. J Surg Res; 1997 Jun; 70(1):12-20. PubMed ID: 9228921 [Abstract] [Full Text] [Related]
12. From the metabolic syndrome to NAFLD or vice versa? Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [Abstract] [Full Text] [Related]
19. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Am J Gastroenterol; 2008 Jun 10; 103(6):1372-9. PubMed ID: 18510618 [Abstract] [Full Text] [Related]